HKEX:719 Short term 20 days. Potential profit 16%HKEX:719 has a head and shoulder pattern. The target is near the previous resistance.
Buy in @3.94
Cut loss @3.68
Target @4.58
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.72 HKD
548.64 M HKD
8.85 B HKD
195.00 M
About SHANDONG XINHUA PH
Sector
CEO
Wen Hui Xu
Headquarters
Zibo
Website
Founded
1943
ISIN
CNE100000411
FIGI
BBG000BD34Z8
Shandong Xinhua Pharmaceutical Co., Ltd. engages in the development, production and sales of pharmaceutical and synthetic chemical products. It operates the business through the following segments: Bulk Pharmaceuticals, Preparations, Chemical and Other Products. The firm's products include analgin, caffeine, amidopyrine, ibuprofen, theophylline, aspirin, hydrocortisone and pipemidic acid. The company also sells pharmaceutical raw materials, preprations, antibiotic preparations, herbal medicine, biological products, medical appliances, chinese medicines and beauty products. Shandong Xinhua Pharmaceutical was founded in 1943 and is headquartered in Zibo, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 719 is 5.84 HKD — it hasn't changed in the past 24 hours. Watch SHANDONG XINHUA PHARMACEUTICAL CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange SHANDONG XINHUA PHARMACEUTICAL CO stocks are traded under the ticker 719.
719 stock has fallen by −0.85% compared to the previous week, the month change is a 2.46% rise, over the last year SHANDONG XINHUA PHARMACEUTICAL CO has showed a 1.74% increase.
719 stock is 1.37% volatile and has beta coefficient of 0.75. Track SHANDONG XINHUA PHARMACEUTICAL CO stock price on the chart and check out the list of the most volatile stocks — is SHANDONG XINHUA PHARMACEUTICAL CO there?
Today SHANDONG XINHUA PHARMACEUTICAL CO has the market capitalization of 3.99 B, it has increased by 4.92% over the last week.
Yes, you can track SHANDONG XINHUA PHARMACEUTICAL CO financials in yearly and quarterly reports right on TradingView.
SHANDONG XINHUA PHARMACEUTICAL CO is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
719 net income for the last quarter is 85.61 M HKD, while the quarter before that showed 133.34 M HKD of net income which accounts for −35.80% change. Track more SHANDONG XINHUA PHARMACEUTICAL CO financial stats to get the full picture.
SHANDONG XINHUA PHARMACEUTICAL CO dividend yield was 4.74% in 2023, and payout ratio reached 33.52%. The year before the numbers were 2.69% and 30.36% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 30, 2024, the company has 7.10 K employees. See our rating of the largest employees — is SHANDONG XINHUA PHARMACEUTICAL CO on this list?
Like other stocks, 719 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANDONG XINHUA PHARMACEUTICAL CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANDONG XINHUA PHARMACEUTICAL CO technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANDONG XINHUA PHARMACEUTICAL CO stock shows the buy signal. See more of SHANDONG XINHUA PHARMACEUTICAL CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.